This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Take Stock Of The Week Ahead

Get all the latest Share Market trends and news to set you up for the week ahead.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Lake Street analyst Frank Takkinen initiated coverage on Axogen, Inc. AXGN with a Buy rating and announced a price target of $30. Axogen shares closed at $17.25 on Friday. See how other analysts view this stock.
  • Craig-Hallum analyst John Wilkin initiated coverage on Personalis, Inc. PSNL with a Buy rating and announced a price target of $8. Personalis shares closed at $3.63 on Friday. See how other analysts view this stock.
  • William Blair analyst Andrew Brackmann initiated coverage on Butterfly Network, Inc. BFLY with an Outperform rating. Butterfly Network shares closed at $2.68 on Friday. See how other analysts view this stock.
  • Roth MKM analyst Craig Irwin initiated coverage on EZCORP, Inc. EZPW with a Buy rating and announced a price target of $16. EZCORP shares closed at $13.45 on Friday. See how other analysts view this stock.
  • Jefferies analyst Michael Yee initiated coverage on Blueprint Medicines Corporation BPMC with a Buy rating and announced a price target of $135. Blueprint Medicines shares closed at $89.58 on Friday. See how other analysts view this stock.

Considering buying BPMC stock? Here’s what analysts think:

Don't miss a beat on the share market. Get real-time updates on top stock movers and trading ideas on Benzinga India Telegram channel.

Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm